Aarti Drugs Limited reports a change in its board or management
In short
Aarti Drugs Limited informed the NSE on August 22, 2026, about a change in directors/KMP/SMP/auditor/RTA. No figures, breakdowns, scheme names, or closing dates were stated in the text. In simple terms, the company is telling the exchange that there has been a personnel or service-provider change in its leadership or related official roles. No validity period or deadline was given.
Why it matters
A change at the leadership or audit level — worth checking who's departing/joining and whether the filing gives a reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.